Cell Source, Inc. Quarterly Debt-to-equity in % from Q3 2016 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Cell Source, Inc. quarterly Debt-to-equity history and growth rate from Q3 2016 to Q3 2024.
  • Cell Source, Inc. Debt-to-equity for the quarter ending September 30, 2024 was -101 %, a 0.73% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 -101 +0.75 +0.73% Sep 30, 2024
Q2 2024 -101 +1.09 +1.06% Jun 30, 2024
Q1 2024 -101 +0.71 +0.7% Mar 31, 2024
Q4 2023 -102 +0.7 +0.68% Dec 31, 2023
Q3 2023 -102 +0.17 +0.17% Sep 30, 2023
Q2 2023 -103 Jun 30, 2023
Q1 2023 -102 Mar 31, 2023
Q4 2022 -102 Dec 31, 2022
Q3 2022 -102 Sep 30, 2022
Q2 2021 -104 -2.13 -2.1% Jun 30, 2021
Q1 2021 -103 -1.73 -1.7% Mar 31, 2021
Q4 2020 -103 -1.65 -1.63% Dec 31, 2020
Q3 2020 -102 -0.77 -0.76% Sep 30, 2020
Q2 2020 -102 Jun 30, 2020
Q1 2020 -102 Mar 31, 2020
Q4 2019 -102 Dec 31, 2019
Q3 2019 -101 Sep 30, 2019
Q4 2016 -104 Dec 31, 2016
Q3 2016 -104 Sep 30, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.